2.476 - 2.500 of 34.064
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Chipotle Call 40,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 8,26x
- Analysis
- Aixtron Call 14,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,62x
- Analysis
- Meta Platforms Call 860,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 9,46x
- Analysis
- RWE St. Call 35,00 18 Jun 2027
- Goldman Sachs
- 18.06.27
- 4,13x
- Analysis
- Super Micro Computer Call 40,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 4,87x
- Analysis
- Deutsche Telekom Call 25,00 18 Jun 2027
- Goldman Sachs
- 18.06.27
- -
- Analysis
- Moderna Call 24,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 3,47x
- Analysis
- R3NK GY Call 60,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 9,35x
- Analysis
- Novo Nordisk Call 285,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,57x
- Analysis
- Alphabet Call 340,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 3,72x
- Analysis
- Commerzbank Call 60,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 5,99x
- Analysis
- Gilead Sciences Call 200,00 18 Sep 2026
- Goldman Sachs
- 18.09.26
- 5,54x
- Analysis
- Meta Platforms Call 1.020,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 16,47x
- Analysis
- Moderna Call 24,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 4,58x
- Analysis
- Novo Nordisk Call 475,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,49x
- Analysis
- Novo Nordisk Call 355,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,96x
- Analysis
- Novo Nordisk Call 255,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,34x
- Analysis
- Henkel Vz. Call 72,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 18,14x
- Analysis
- Meta Platforms Call 810,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 27,10x
- Analysis
- Novo Nordisk Call 525,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,57x
- Analysis
- Novo Nordisk Call 415,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,20x
- Analysis
- Novo Nordisk Call 295,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,66x
- Analysis
- Novo Nordisk Call 305,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,74x
- Analysis
- Novo Nordisk Call 275,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,49x
- Analysis
- Novo Nordisk Call 385,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,97x
- Analysis